Microbial Pathogenesis in Cystic Fibrosis: Mucoid Pseudomonas Aeruginosa and Burkholderia Cepacia

Overview

Journal Microbiol Rev

Publisher American Society for Microbiology

Specialty Microbiology

Date 1996 Sep 1

PMID 8840786

Citations 703

Authors

J R Govan

V Deretic

Affiliations

Soon will be listed here.

Abstract

Respiratory infections with Pseudomonas aeruginosa and Burkholderia cepacia play a major role in the pathogenesis of cystic fibrosis (CF). This review summarizes the latest advances in understanding host-pathogen interactions in CF with an emphasis on the role and control of conversion to mucoidy in P. aeruginosa, a phenomenon epitomizing the adaptation of this opportunistic pathogen to the chronic chourse of infection in CF, and on the innate resistance to antibiotics of B. cepacia, person-to-person spread, and sometimes rapidly fatal disease caused by this organism. While understanding the mechanism of conversion to mucoidy in P. aeruginosa has progressed to the point where this phenomenon has evolved into a model system for studying bacterial stress response in microbial pathogenesis, the more recent challenge with B. cepacia, which has emerged as a potent bona fide CF pathogen, is discussed in the context of clinical issues, taxonomy, transmission, and potential modes of pathogenicity.

Citing Articles

Understanding the pathophysiology of colonization as a guide for future treatment for chronic leg ulcers.

Matheus G, Chamoun M, Khosrotehrani K, Sivakumaran Y, Wells T Burns Trauma. 2025; 13():tkae083.

PMID: 39830194 PMC: 11741523. DOI: 10.1093/burnst/tkae083.

Hypermutability bypasses genetic constraints in SCV phenotypic switching in Pseudomonas aeruginosa biofilms.

Tobares R, Martino R, Colque C, Castillo Moro G, Moyano A, Albarracin Orio A NPJ Biofilms Microbiomes. 2025; 11(1):14.

PMID: 39805827 PMC: 11730322. DOI: 10.1038/s41522-024-00644-z.

PEG-PLGA nanoparticles deposited in and .

Tchatchiashvili T, Duering H, Mueller-Boetticher L, Grune C, Fischer D, Pletz M J Pharm Anal. 2025; 14(12):100939.

PMID: 39759775 PMC: 11697766. DOI: 10.1016/j.jpha.2024.01.007.

New tools to monitor infection and biofilms in .

Xue F, Ragno M, Blackburn S, Fasseas M, Maitra S, Liang M Front Cell Infect Microbiol. 2024; 14:1478881.

PMID: 39737329 PMC: 11683784. DOI: 10.3389/fcimb.2024.1478881.

Urinary tract infections and catheter-associated urinary tract infections caused by .

El Husseini N, Carter J, Lee V Microbiol Mol Biol Rev. 2024; 88(4):e0006622.

PMID: 39431861 PMC: 11653733. DOI: 10.1128/mmbr.00066-22.

References

Roychoudhury S, Sakai K, Schlictman D, Chakrabarty A . Signal transduction in exopolysaccharide alginate synthesis: phosphorylation of the response regulator AlgR1 in Pseudomonas aeruginosa and Escherichia coli. Gene. 1992; 112(1):45-51. DOI: 10.1016/0378-1119(92)90301-5. View

Darzins A, Nixon L, Vanags R, Chakrabarty A . Cloning of Escherichia coli and Pseudomonas aeruginosa phosphomannose isomerase genes and their expression in alginate-negative mutants of Pseudomonas aeruginosa. J Bacteriol. 1985; 161(1):249-57. PMC: 214864. DOI: 10.1128/jb.161.1.249-257.1985. View

Pier G, Desjardins D, Aguilar T, Barnard M, Speert D . Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients. J Clin Microbiol. 1986; 24(2):189-96. PMC: 268873. DOI: 10.1128/jcm.24.2.189-196.1986. View

Wozniak D, Ohman D . Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT. J Bacteriol. 1994; 176(19):6007-14. PMC: 196818. DOI: 10.1128/jb.176.19.6007-6014.1994. View

Steinbach S, Sun L, Jiang R, Flume P, Gilligan P, Egan T . Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med. 1994; 331(15):981-7. DOI: 10.1056/NEJM199410133311504. View

Pfeffer K, Huecksteadt T, Hoidal J . Expression and regulation of tumor necrosis factor in macrophages from cystic fibrosis patients. Am J Respir Cell Mol Biol. 1993; 9(5):511-9. DOI: 10.1165/ajrcmb/9.5.511. View

Kubesch P, Dork T, Wulbrand U, Kalin N, Neumann T, Wulf B . Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis. Lancet. 1993; 341(8839):189-93. DOI: 10.1016/0140-6736(93)90062-l. View

May T, Shinabarger D, Maharaj R, Kato J, Chu L, DeVault J . Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev. 1991; 4(2):191-206. PMC: 358191. DOI: 10.1128/CMR.4.2.191. View

Heidt A, Monteil H, Richard C . O and H serotyping of Pseudomonas cepacia. J Clin Microbiol. 1983; 18(3):738-40. PMC: 270889. DOI: 10.1128/jcm.18.3.738-740.1983. View

10.

Mortensen J, Fisher M, LiPuma J . Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol. 1995; 16(1):30-2. DOI: 10.1086/646999. View

11.

Allison D, Goldsbrough M . Polysaccharide production in Pseudomonas cepacia. J Basic Microbiol. 1994; 34(1):3-10. DOI: 10.1002/jobm.3620340102. View

12.

Bedard M, McCLURE C, Schiller N, Francoeur C, Cantin A, Denis M . Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am J Respir Cell Mol Biol. 1993; 9(4):455-62. DOI: 10.1165/ajrcmb/9.4.455. View

13.

Rommens J, Iannuzzi M, Kerem B, Drumm M, Melmer G, Dean M . Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989; 245(4922):1059-65. DOI: 10.1126/science.2772657. View

14.

Gabriel S, Brigman K, Koller B, Boucher R, Stutts M . Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science. 1994; 266(5182):107-9. DOI: 10.1126/science.7524148. View

15.

Martin D, Schurr M, Yu H, Deretic V . Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress response. J Bacteriol. 1994; 176(21):6688-96. PMC: 197026. DOI: 10.1128/jb.176.21.6688-6696.1994. View

16.

Roop 2nd R, Fletcher T, Sriranganathan N, Boyle S, Schurig G . Identification of an immunoreactive Brucella abortus HtrA stress response protein homolog. Infect Immun. 1994; 62(3):1000-7. PMC: 186216. DOI: 10.1128/iai.62.3.1000-1007.1994. View

17.

Komiyama K, Habbick B, Tumber S . Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients. Infect Immun. 1987; 55(10):2364-9. PMC: 260714. DOI: 10.1128/iai.55.10.2364-2369.1987. View

18.

Simpson J, Smith S, Dean R . Alginate may accumulate in cystic fibrosis lung because the enzymatic and free radical capacities of phagocytic cells are inadequate for its degradation. Biochem Mol Biol Int. 1993; 30(6):1021-34. View

19.

Otterlei M, Ostgaard K, Skjak-Braek G, Smidsrod O, Soon-Shiong P, Espevik T . Induction of cytokine production from human monocytes stimulated with alginate. J Immunother (1991). 1991; 10(4):286-91. DOI: 10.1097/00002371-199108000-00007. View

20.

Bye M, Ewig J, Quittell L . Cystic fibrosis. Lung. 1994; 172(5):251-70. DOI: 10.1007/BF00164308. View